São Paulo, October 19, 2023 – Euro Health Innovation Award’s second edition was held late on Wednesday 18, at Tokio Marine Hall, in São Paulo, and acknowledged the most innovative projects, selected by physicians from across Latin America throughout 2023. The night’s main moment was the announcement of the Award’s Highlight Initiative, which was the project “Calixcoca – Therapeutic vaccine for treatment of cocaine and crack addiction”, by physician Frederico Duarte Garcia, who will receive € 500,000.00 (five hundred thousand Euros). To the other 11 winning projects € 50,000.00 (fifty thousand Euros) awards were distributed).

“This was a very special night, where we could actually celebrate medical innovations in Brazil, and, for the first time, also in the other 16 Latin American countries where Eurofarma is present. We were very glad to be close to such an engaged scientific community, and to bring to the society innovations that can really change people’s lives”, said Roberta Junqueira, Eurofarma’s Commercial director.

Altogether, 11 projects from Brazil, from four different states, were the winners, in addition to an unprecedented acknowledgement of one initiative from Uruguay. They were all chosen by open voting by Latin American physicians.  The Euro Award objective is to acknowledge and encourage the search for solutions in products, services, and innovative actions that will improve life quality and well-being of Brazilians and Latin American citizens.

The authors of other well positioned projects from other countries, which were not winners, were also present at the event; a way to encourage Latin America participation, since this was the first edition that included other countries besides Brazil. Eurofarma, increasingly global, is committed to expand its initiatives to all places where it operates, thus contribution to the medical community and the whole society.

Check below the highlights and other winners:

The awards night also counted on a special closing show with Filhos da Música group, comprising Wilson Simoninha, Léo Maia, Max de Castro and Max Viana, sons of great artists Wilson Simonal, Tim Maia and Djavan. The group sang major classics of the Brazilian music.   

To learn more about Euro Award, access premioeuro.com.

About Eurofarma

Founded in 1972, Eurofarma operates in the healthcare sector by producing and trading products and services, in order to improve people’s life quality. Focused on generating shared value, its operation comprises all main pharmaceutical segments like Medical Prescription, Generic medicines, OTC, Hospital, and Oncology. With a broad coverage of therapeutic classes, the portfolio in the region includes 2.8 thousand SKUs, and serves 42 medical specialties.  Present in 22 countries, mainly in Latin America, it also keeps operations in the USA and Africa. With over 11 thousand employees, in 2022, started to be registered as publicly-held company with the Securities and Exchange Commission (CVM).

It reported R$ 8 billion as net revenue, 13.3% growth against the previous year, with R$ 2 billion as ebitda, 20% evolution. In R&D, investments in the year amounted to over R$ 590 million, corresponding to 7.4% of the net revenue. In the last decade, the company recorded average growth of 17% a year, and won leading position in medical prescription, and vice-leader in the generics segment in Brazil.  

Eurofarma on social media
Facebook: @eurofarma | LinkedIn: @eurofarma
Instagram: @eurofarma | Youtube: @eurofarmalab

Information to press

G&A – Public Relations 

Kelly Casarin - 11 98262-0148 – kelly.casarin@gaspar.com.br

Sarah Cardoso - 11 94821-0883 – sarah.cardoso@gaspar.com.br

Guilherme Gaspar - 11 98285-6000 – guilherme@gaspar.com.br